Latest Conference Articles

Here's the latest innovations at Neurotech Pharmaceuticals, Inc. 

Selective laser trabeculoplasty (SLT) could be an affordable option for glaucoma management, according to Nathan Radcliffe, MD. 

Dr Jacqueline Beltz, FRANZCO, shares the take-home message from her 2019 ASCRS presentation

Topical drug for the treatment of dry eye disease sees potential 

E. Randy Craven, MD, shares results from a phase 1/2 study involving an intracameral bimatoprost sustained-release implant. 

Laura M. Periman, MD, shares how IPL therapy can quickly rid patients of painful chalazions

Audrey Talley Rostov, MD, discusses corneal cross-linking (CXL) complications, and when to consider CXL treatment 

Retina specialist Ron M. Kurtz, MD, details the way collaborative innovation can improve the lives of ophthalmic surgeons, and their patients.

Patients prefer the convenience of using a compounded triple combination drop over a standard medication plan.

A technique to assure complete separation of the cap and prevent a radial tear has been perfected by Steve Arshinoff, MD. 

Sara Anastas, MD, discusses criteria for surgical intervention methods with either corneal crosslinking (CXL) or penetrating keratoplasty in pediatric patients.

Providing findings from a retrospective study, Li Lim, MD, noted that eyes with high myopia benefit from CXL add-on to LASIK, resulting in safety, efficacy, and predictability with refractive outcomes that are more stable than those achieved with LASIK alone. 

The registry provides real-world evidence of safety, and durable efficacy of a glaucoma surgery device.  

Stephen C. Pflugfelder, MD, honored as the recipient of the Binkhorst Lecture and medal at ASCRS 2019, lectured on the quest for tear stability in dry eye patients. 

New technology offers surgeons the unfolding efficiency of an enhanced material along with the rotational stability that characterizes the current toric platform. 

Corneal surgery for Fuchs’ rejuvenates the endothelium rather than replacing it, and DSO is joining the lineup as a new treatment option.

During Refractive Day at ASCRS 2019, Julie Schallhorn, MD, MS, shed some new light on the topic by challenging conventional wisdom about dry eye and LASIK. 

A carefully packed surgical toolkit can optimize cataract surgery outcomes.

If you find yourself waffling back and forth on private equity, Ruth D. Williams, MD, has some guidance tips to make the decision easier. 

Janey L. Wiggs, MD, PhD, shares the key points from her presentation.

Ellie Chabi, MD, Therapeutic Area Head for Glaucoma & Neuroprotection and Lead for Artificial Intelligence Programs within Global Biomedical Science for Santen, provides an update on its glaucoma pipeline.

Joel S. Schuman, MD, FACS, shares what's in store for regenerative ophthalmology at the annual Glaucoma 360 2019 meeting. 

Robert L. Stamper, MD, discusses the current state of OCT angiography, and what remains on the horizon for glaucoma care.

Yvonne Ou, MD, discusses Glaucoma 360's first-ever "Shark Tank" competition at the 2019 meeting.

Drs. Graves and Iwach, co-founders of the Glaucoma 360 meeting, discuss the biggest advances in innovation and research at the 23rd annual meeting at the Palace Hotel in San Francisco on Feb. 2, 2019.

Shan C. Lin, MD, provides the key takeaways from his presentation at the annual Glaucoma 360 meeting.

The 2019 annual meetings of the American Society of Cataract and Refractive Surgery and the American Society of Ophthalmic Administrators will be held May 3 to 7 in San Diego.

L. Jay Katz, MD, delivered the Shaffer‐Hetherington‐Hoskins Lecture, "Screening for Glaucoma: New Strategies" at the 23rd annual Glaucoma 360 meeting at the Palace Hotel in San Francisco on Feb. 2, 2019. Here, he shares his take-home message for clinicians.